-
Mashup Score: 4Program Guide – ASCO Meeting Program Guide - 8 hour(s) ago
Toni Choueiri , Jae Lyun Lee , Jaime Merchan , Amita Patnaik , Benjamin Garmezy , Alexandra Drakaki , Moshe Ornstein , Bradley McGregor , Ralph Hauke , Kai Tsao , Brian Rini , Pedro Barata , Paul Foster , Sutapa Mukhopadhyay , Neal Gupta , Jianfen Chen , Manish Monga , Dimitry Nuyten , Sun Young Rha Dana-Farber Cancer Institute and Harvard Medical School, Asan Medical Center, University of Ulsan College of Medicine, University of Miami Sylvester Comprehensive Cancer Center, The START Center for Cancer
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11Program Guide – ASCO Meeting Program Guide - 9 hour(s) ago
Toni Choueiri , Jae Lyun Lee , Jaime Merchan , Amita Patnaik , Benjamin Garmezy , Alexandra Drakaki , Moshe Ornstein , Bradley McGregor , Ralph Hauke , Kai Tsao , Brian Rini , Pedro Barata , Paul Foster , Sutapa Mukhopadhyay , Neal Gupta , Jianfen Chen , Manish Monga , Dimitry Nuyten , Sun Young Rha Dana-Farber Cancer Institute and Harvard Medical School, Asan Medical Center, University of Ulsan College of Medicine, University of Miami Sylvester Comprehensive Cancer Center, The START Center for Cancer
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#441 @ASCO #GU25 by @DrChoueiri👉https://t.co/ZcSpDFQN59👉Ph1 ARC-20 study #kidneycancer👉novel HIF-2α inhibitor Casdatifan👉well tolerated with promising early clinical activity in heavily treated mRCC👇#SunYoungRha @OncoAlert @urotoday @Uromigos @KidneyCancer @kidneycan https://t.co/3Ocrx2VbT6
-
Ab#441 @ASCO #GU25 by @DrChoueiri👉https://t.co/ZcSpDFQN59👉Ph1 ARC-20 study #kidneycancer👉novel HIF-2α inhibitor Casdatifan👉well tolerated with promising early clinical activity in heavily treated mRCC👇#SunYoungRha @OncoAlert @urotoday @Uromigos @KidneyCancer @kidneycan https://t.co/3Ocrx2VbT6